{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:08:02Z","timestamp":1740136082034,"version":"3.37.3"},"reference-count":7,"publisher":"The Endocrine Society","issue":"7","license":[{"start":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T00:00:00Z","timestamp":1673568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,16]]},"DOI":"10.1210\/clinem\/dgad017","type":"journal-article","created":{"date-parts":[[2023,1,14]],"date-time":"2023-01-14T01:41:55Z","timestamp":1673660515000},"page":"e493-e494","source":"Crossref","is-referenced-by-count":0,"title":["Liraglutide in Prader Willi\u2013Syndrome: The Importance of Placebo-Controlled Studies"],"prefix":"10.1210","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8517-0241","authenticated-orcid":false,"given":"Carlos A","family":"Aguilar Salinas","sequence":"first","affiliation":[{"name":"Direction of Nutrition, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, Mexico City 14080 , Mexico"},{"name":"Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud , Ave. Morones Prieto 3000, Monterrey, NL, 64710 , M\u00e9xico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2191-4931","authenticated-orcid":false,"given":"Rita A","family":"G\u00f3mez D\u00edaz","sequence":"additional","affiliation":[{"name":"Unidad de Investigaci\u00f3n M\u00e9dica en Epidemiolog\u00eda Cl\u00ednica, UMAE Hospital de Especialidades, Centro M\u00e9dico Nacional Siglo XXI, Instituto Mexicano del Seguro Social (IMSS) , Mexico City 06720 , Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2023,1,13]]},"reference":[{"issue":"6","key":"2023061601040714200_dgad017-B1","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1210\/clinem\/dgac082","article-title":"Approach to the patient with Prader-Willi syndrome","volume":"107","author":"H\u00f6ybye","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2023061601040714200_dgad017-B2","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1007\/s40618-021-01574-9","article-title":"Obesity in Prader-Willi syndrome: physiopathological mechanisms, nutritional and pharmacological approaches","volume":"44","author":"Muscogiuri","year":"2021","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"2023061601040714200_dgad017-B3","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1210\/clinem\/dgac549","article-title":"Liraglutide for weight management in children and adolescents with Prader\u2013Willi syndrome and obesity","volume":"108","author":"Tauber","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2023061601040714200_dgad017-B4","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1507\/endocrj.EJ12-0074","article-title":"The glucagon-like peptide-1 analog liraglutide suppresses ghrelin and controls diabetes in a patient with Prader-Willi syndrome","volume":"59","author":"Senda","year":"2012","journal-title":"Endocr J"},{"issue":"1","key":"2023061601040714200_dgad017-B5","doi-asserted-by":"crossref","first-page":"52","DOI":"10.6065\/apem.2020.25.1.52","article-title":"Successful rapid weight reduction and the use of liraglutide for morbid obesity in adolescent Prader-Willi syndrome","volume":"25","author":"Kim","year":"2020","journal-title":"Ann Pediatr Endocrinol Metab"},{"issue":"4","key":"2023061601040714200_dgad017-B6","doi-asserted-by":"crossref","first-page":"352","DOI":"10.4103\/sja.SJA_124_19","article-title":"Is positive publication bias really a bias, or an intentionally created discrimination toward negative results?","volume":"13","author":"Sharma","year":"2019","journal-title":"Saudi J Anaesth"},{"key":"2023061601040714200_dgad017-B7","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgac678","article-title":"Approach to the patient with hypothalamic obesity","volume":"108","author":"Shoemaker","year":"2023","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgad017\/48956992\/dgad017.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/108\/7\/e493\/50604867\/dgad017.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/108\/7\/e493\/50604867\/dgad017.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T02:02:07Z","timestamp":1686880927000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/108\/7\/e493\/6987153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,13]]},"references-count":7,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,1,13]]},"published-print":{"date-parts":[[2023,6,16]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgad017","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"type":"print","value":"0021-972X"},{"type":"electronic","value":"1945-7197"}],"subject":[],"published-other":{"date-parts":[[2023,7]]},"published":{"date-parts":[[2023,1,13]]}}}